Pharmacological interventions for schizotypal personality disorder

Cochrane Database of Systematic Reviews

Volumn 2014, Issue 3, 2014, Pages

  Farooq, Saeed ^a   Völlm, Birgit A ^b   Husain, Nusrat ^c   Huband, Nick ^b   Stoffers, Jutta M ^d   Gibbon, Simon ^e   Duggan, Conor ^b   Ferriter, Michael ^f   Lieb, Klaus ^g  

^a STAFFORDSHIRE UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d UNIVERSITY OF FREIBURG   (Germany)

^e NOTTINGHAMSHIRE HEALTHCARE NHS TRUST   (United Kingdom)

^f RAMPTON HOSPITAL   (United Kingdom)

^g UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; PRIORITY JOURNAL; RETRACTED ARTICLE;

EID: 84863787766     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD009047.pub2     Document Type: Article

References (36)

1. Alltman DG, Bland JM. Detecting skewedness from summary information. BMJ 1996;313(7066):1200.
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. DSM-IV. 4th Edition. Washington, DC: American Psychiatric Association, 1994.
3. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. DSM-IV-TR. 4th Edition. Washington, DC: American Psychiatric Association, 2000.
4. Baron M, Gruen R, Rainer JD, et al.A family study of schizophrenic and normal control probands: implications for the spectrum concept of schizophrenia. American Journal of Psychiatry 1985;142:447-55.
5. Joint Formulary Committee. British National Formulary: 59.0. London: British Medical Association and Royal Pharmaceutical Society, 2010 [March].
6. Cloninger CR. A systematic method for clinical description and classification of personality variants. Archives of General Psychiatry 1987;44:573-88.
7. Coid J. Epidemiology, public health and the problem of personality disorder. The British Journal of Psychiatry 2003;182:s3-s10.
8. Costa PT, McCrae RR. NEO PI-R Professional Manual. Odessa, FL: Psychological Assessment Resources, 1992.
9. Derogatis LR. SCL-90-R, Brief Symptom Inventory, and matching clinical rating scales. In: Maruish M editor(s). Psychological Testing, Treatment Planning and Outcome Assessment. New York, NY: Erlbaum, 1994.
10. Donner A, Koval JJ. The estimation of intraclass correlation in the analysis of family data. Biometrics 1980;36:19-25.
11. Duggan C, Huband N, Smailagic N, Ferriter M, Adams C. The use of psychological treatments for people with personality disorder: a systematic review of randomised controlled trials. Journal of Personality and Mental Health 2007;1:95-125.
12. Duggan C, Huband N, Smailagic N, Ferriter M, Adams C. The use of pharmacological treatments for people with personality disorder: a systematic review of randomized controlled trials. Journal of Personality and Mental Health 2008;2:119-70.
13. Egger M, Davey-Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34.
14. Elbourne DR, Altman DG, Higgins JP, Curtin F, Worthington HV, Vail A. Meta-analyses involving cross-over trials: methodological issues. International Journal of Epidemiology 2002;31(1):140-9.
15. Endicott J, Spitzer RL, Fleiss JL, Cohen J. The global assessment scale: a procedure for measuring overall severity of psychiatric disturbance. Archives of General Psychiatry 1976;33:766-71.
16. First MB, Gibbon M, Spitzer RL, Williams JBW, Benjamin LS. Structured clinical interview for DSM-IV Axis II personality disorders (SCID-II). Washington, DC: American Psychiatric Press, 1997.
17. Follmann D, Elliott P, Suh I, Cutler J. Variance imputation for the overviews of clinical trials with continuous response. Journal of Clinical Epidemilogy 1992;45:769-73.
18. Gamble C, Hollis S. Uncertainty method on best-worst case analysis in a binary meta-analysis. Journal of Clinical Epidemiology 2005;58(6):579-88.
19. Guy W. ECDEU Assessment Manual for Psychoparmacology-Revised. DHEW Publ No ADM 76-338. Rockville, MD: U.S. Department of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, NIMH Psychopharmacology Research Branch, Division of Extramural Research Programs, 1976:218-22.
20. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions 5.0.2 [updated September 2009]. The Cochrane Collaboration, 2009. Available from www.cochrane-handbook.org.
21. Hyler SE. Personality Diagnostic Questionnaire-4. New York, NY: New York State Psychiatric Institute, 1994.
22. Livesley WJ, Jang KL, Jackson DN, Vernon PA. Genetic and environmental contributions to dimensions of personality disorder. American Journal of Psychiatry 1993;150:1826-31.
23. McGorry PD, Yung AR, Phillips LJ. Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Archives of General Psychiatry 2002;59(10):921-8.
24. Morrison AP, French P, Walford L. Cognitive therapy for the prevention of psychosis in people at ultra-high risk: randomised controlled trial. British Journal of Psychiatry 2004;185:291-7.
25. Morrison AP, French P, Parker PS, Roberts M, Stevens H, Bentall RP, Lewis SW. Three-year follow-up of a randomized controlled trial of cognitive therapy for the prevention of psychosis in people at ultra-high risk. Schizophrenia Bulletin 2007;33(3):682-7.
26. Morrison AP, French P, Walford L. Cognitive therapy for the prevention of psychosis in people at ultra-high risk: Randomised controlled trial. British Journal of Psychiatry 2004;185:291-7.
27. Pfohl B, Blum N, Zimmerman M. Structured Interview for DSM-IV Personality Disorders. Washington, DC: American Psychiatric Press, 1997.
28. Siever LJ, Davis KL. The Pathophysiology of Schizophrenia Disorders: Perspectives From the Spectrum. American Journal of Psychiatry 2004;161:398-413.
29. Sievwright H, Tyrer P, Johnson T. Change in personality status in neurotic disorders. The Lancet 2002;359:2253-4.
30. Skodol AE, Gunderson JG, McGlashan TH, Dyck IR, Stout RL, Bender, et al.Functional impairment in patients with schizotypal, borderline, avoidant, or obsessive-compulsive personality disorder. American Journal of Psychiatry 2002;159:276-83.
31. Soloff PH. Algorithms for pharmacological treatment of personality dimensions. Symptom-specific treatments for cognitive-perceptual, affective, and impulsive-behavioral dysregulation. Bulletin of the Menninger Clinic 1998;62:195-214.
32. Torgersen S, Kringlen E, Cramer V. The prevalence of personality disorders in a community sample. Archives of General Psychiatry 2001;58:590-6.
33. Tyrer P, Nur U, Crawford M. The Social Functioning Questionnaire: a rapid and robust measure of perceived functioning. International Journal of Social Psychiatry 2005;51:265-75.
34. Weissman MM, Bothwell S. Assessment of social adjustment by patient self-report. Archives of General Psychiatry 1976;33:1111-5.
35. World Health Organization. The ICD-10 classification of mental and behavioural disordeers. Clinical descriptions and diagnostic guidelines. 10th Edition. Geneva: World Health Organization, 1992.
36. Yung AR, McGorry PD, McFarlane CA, Jackson HJ, Patton GC, Rakkar A. Monitoring and care of young people at incipient risk of psychosis. Schizophrenia Bulletin 1996;22:283-303.